Loading…
10x Genomics, Inc. is projected to rise to $62.53 by 2027, a +27% move from its current price of $49.43. TXG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $47.62 | $49.47 | $51.39 | +0.08% |
| Aug 2 | $46.92 | $49.51 | $52.25 | +0.16% |
| Aug 3 | $46.39 | $49.55 | $52.92 | +0.24% |
| Aug 4 | $45.96 | $49.59 | $53.51 | +0.32% |
| Aug 5 | $45.58 | $49.63 | $54.04 | +0.40% |
| Aug 6 | $45.25 | $49.67 | $54.52 | +0.48% |
| Aug 7 | $44.95 | $49.71 | $54.97 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $44.95 | $49.71 | $54.97 | +0.56% |
| Week 2 | $43.36 | $49.99 | $57.64 | +1.13% |
| Week 3 | $42.23 | $50.27 | $59.85 | +1.70% |
| Week 4 | $41.34 | $50.55 | $61.83 | +2.27% |
| Week 5 | $40.59 | $50.84 | $63.67 | +2.85% |
| Week 6 | $39.95 | $51.13 | $65.42 | +3.43% |
| Week 7 | $39.39 | $51.41 | $67.10 | +4.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
10x Genomics, Inc. is a healthcare technology company that develops and sells instruments, consumables, and software for analyzing biological systems. Its product portfolio includes the Chromium platform, a single cell portfolio with microfluidic chips and related consumables, Chromium X Series, and Chromium instruments, as well as QuantumScale single cell RNA and single cell methylation kits.
The company also offers the Visium platform for spatial analysis and the Xenium Analyzer to detect RNA targets directly in tissue sections, along with related slides and reagents. Software offerings include Cell Ranger, Loupe Browser, and Xenium Explorer. 10x Genomics serves academic, government, biopharmaceutical, biotechnology, and other institutions, and is headquartered in Pleasanton, California.
The company was incorporated in 2012 and was formerly known as 10X Technologies, Inc., changing its name to 10x Genomics, Inc. in November 2014.
TXG is the ticker for 10x Genomics, Inc. Its current price is $47.20 with a market cap of $5.99B, and it is ranked 1236 by market capitalization. The stock trades in a 30-day range from $35.56 to $62.65, with a near-term setup showing bullish sentiment alongside a current price near resistance at $47.20.
The near-term technical picture is complemented by a bullish longer-term outlook, with multi-year forecasts indicating substantial upside potential from 2026 through 2050.
A major floor 61.3% below — a decisive break under it would weaken the trend.
The nearest floor, 35.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 23.7% above — clearing it would confirm fresh momentum.
Key TXG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TXG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $47.00 | Buy | $47.43 | Buy |
| MA 10 | $46.43 | Buy | $46.37 | Buy |
| MA 20 | $44.11 | Buy | $43.93 | Buy |
| MA 50 | $36.09 | Buy | $37.63 | Buy |
| MA 100 | $28.75 | Buy | $31.63 | Buy |
| MA 200 | $23.18 | Buy | $25.84 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 69.75 | Neutral |
| Stoch RSI (14) | 55.59 | Neutral |
| CCI (20) | 126.16 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | 7.95 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 1.40 | Buy |
| Awesome (5,34) | 7.08 | Buy |
| Ultimate (7,14,28) | 65.20 | Neutral |
| Momentum (10) | 4.95 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 47.37 | Buy |
| ADX (14) | 35.93 | Buy |
| ATR (14) | 1.40 | Info |
The 30-day technical picture shows bullish momentum, with RSI(14) at 70. The stock’s short-term moving averages indicate an uptrend, with the SMA50 at $32.45 and the SMA200 at $21.95. Support sits at $28.84 and resistance at $47.20, while the 30-day trading range spans $35.56 to $62.65, highlighting significant upside potential but also volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $16.62 | $49.43 | $69.25 | 0% | Neutral | |
| $48.08 | $62.53 | $86.99 | +27% | Bullish | |
| $61.11 | $82.81 | $121.04 | +68% | Bullish | |
| $78.75 | $110.43 | $167.71 | +123% | Bullish | |
| $88.97 | $128.64 | $201.66 | +160% | Bullish | |
| $87.45 | $130.03 | $209.54 | +163% | Bullish | |
| $96.48 | $147.29 | $243.23 | +198% | Bullish | |
| $103.84 | $162.53 | $274.38 | +229% | Bullish | |
| $103.76 | $166.33 | $286.53 | +236% | Bullish | |
| $137.55 | $225.63 | $396.01 | +356% | Bullish | |
| $167.17 | $305.13 | $578.64 | +517% | Bullish | |
| $368.10 | $816.56 | $1,729.62 | +15.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $16.62 | $49.43 | $57.81 | +0.00% |
| August 2026 | $44.08 | $52.17 | $63.50 | +5.54% |
| September 2026 | $44.42 | $53.19 | $65.94 | +1.95% |
| October 2026 | $42.57 | $51.46 | $64.72 | -3.25% |
| November 2026 | $42.60 | $51.90 | $66.04 | +0.85% |
| December 2026 | $43.89 | $53.86 | $69.25 | +3.78% |
Click any year to see its month-by-month TXG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TXG to range from $16.62 to $69.25 through 2026. The $49.43 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The TXG price prediction for 2027 points to an average of $62.53 (low $48.08, high $86.99) — a potential gain of +27% on today's $49.43. Buyers look set to stay in control over this stretch.
In 2028, TXG is projected to trade between $61.11 and $121.04, averaging $82.81 — a potential gain of +68% from today's $49.43. That is up +32% on the projected 2027 average. Momentum favours further upside here.
10x Genomics, Inc.'s 2029 outlook centres on $110.43, within a $78.75 to $167.71 range. That is up +33% on the projected 2028 average. That marks a +123% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, TXG could reach as high as $201.66, with a base case around $128.64 and support toward $88.97 — roughly +160% from $49.43. Momentum favours further upside here.
Expect TXG to range from $87.45 to $209.54 through 2031. The $130.03 average target implies a +163% move from current prices. That is up +1% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The TXG price prediction for 2032 points to an average of $147.29 (low $96.48, high $243.23) — a potential gain of +198% on today's $49.43. Momentum favours further upside here.
In 2033, TXG is projected to trade between $103.84 and $274.38, averaging $162.53 — a potential gain of +229% from today's $49.43. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
10x Genomics, Inc.'s 2034 outlook centres on $166.33, within a $103.76 to $286.53 range. That is up +2% on the projected 2033 average. That marks a +236% change versus current levels. Momentum favours further upside here.
By 2035, TXG could reach as high as $396.01, with a base case around $225.63 and support toward $137.55 — roughly +356% from $49.43. Buyers look set to stay in control over this stretch.
Expect TXG to range from $167.17 to $578.64 through 2040. The $305.13 average target implies a +517% move from current prices. That is up +35% on the projected 2035 average. Momentum favours further upside here.
The TXG price prediction for 2050 points to an average of $816.56 (low $368.10, high $1,729.62) — a potential gain of +15.5x on today's $49.43. Buyers look set to stay in control over this stretch.
Investing $1,000 in TXG today (≈ 20.230629 TXG) could be worth
$16,519.52
+$15,519.52 (+1552%) by 2050 · US Dollar
Based on the average projected TXG price of $816.56 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TXGwould be worth at today's price.
$1,000 invested in TXG on Jul 30, 2025 (≈ 71.890727 TXG) would be worth
$3,553.56
+$2,553.56 (+255.4%) today · 3.55× · US Dollar
Based on a TXG entry price of $13.91 vs. today's $49.43.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $48.06 | $1,028.51 | +2.9% |
| 1 month ago | $38.34 | $1,289.25 | +28.9% |
| 3 months ago | $22.43 | $2,203.74 | +120.4% |
| 6 months ago | $20.2 | $2,447.03 | +144.7% |
| 1 year ago | $13.91 | $3,553.56 | +255.4% |
| All time (5.0y) ago | $178.24 | $277.32 | -72.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TXG forecast.
Our base-case forecast reaches $99.00 around 2029.
Implied market cap at $99.00: $11.57B
The multi-year forecast portrays a bullish trajectory with rising average prices and expanding upside across years. In 2026, the avg is $47.20 with an ROI of 0% and neutral sentiment. By 2027, the avg is $57.96 (ROI 22.8%, bullish); 2028 shows $79.98 (69.5%, bullish); 2029 $106.84 (126.3%, bullish).
By 2030 the avg is $123.57 (161.8%, bullish), then 2031 $127.17 (169.4%), 2032 $141.63 (200.1%), 2033 $153.37 (224.9%), 2034 $156.55 (231.7%), and 2035 $213.68 (352.7%). The forecast continues with 2040 at $291.12 (516.8%) and 2050 at $784.42 (1,561.9%), all with bullish sentiment. These figures are estimates and not guarantees, reflecting a possible growth path with higher potential upside alongside notable risk and uncertainty.
Tap a question to reveal the answer.
In 2030, the forecast shows min $82.56, avg $123.57, max $200.36, with an ROI of 161.8% and a BULLISH sentiment.
The forecast depicts a bullish sentiment from 2027 onward, with rising average prices and positive ROIs (e.g., 22.8% in 2027, 161.8% in 2030, up to 1,561.9% by 2050). These are estimates and not guarantees.
Yes. The 2033 forecast shows an average of $153.37 with a max of $269.51, and by 2032 the max is $242.99, indicating a move above $150 is possible within the forecast horizon.
The current price is $47.20.
The 30-day range is $35.56 to $62.65.
10x Genomics, Inc. Community Discussion
0Share your 10x Genomics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.